Browse by Audience
Skip to content
Papers of the Week
ART26.12, a novel fatty acid-binding protein 5 inhibitor, shows efficacy in multiple preclinical neuropathy models.
Authors
Warren WG, Osborn M, David-Pereira A, Tsantoulas C, Xue W, Yates A, OSullivan SEAbstract
Painful neuropathy is a pathological condition caused by numerous factors including diabetes, chemotherapy or cancer. ART26.12 is a novel fatty acid-binding protein 5 inhibitor, which our group showed could prevent and treat persistent pain in a preclinical model of oxaliplatin-induced peripheral neuropathy.